Treatment Options for Heavy Menstrual Bleeding
The most effective first-line treatment for heavy menstrual bleeding is the levonorgestrel-releasing intrauterine device (LNG-IUD), which reduces menstrual blood loss by 71-95% while providing contraception. 1
First-Line Treatment Options
- Levonorgestrel-releasing IUD (LNG-IUD): Most effective first-line treatment, reducing menstrual blood loss by 71-95% 1, 2
- NSAIDs for short-term treatment (5-7 days) during days of bleeding:
- Tranexamic acid: Non-hormonal option that reduces bleeding by 26-60%, more effective than NSAIDs and oral progestins 5, 6
Second-Line Treatment Options
- Cyclic oral progestins: Reduce bleeding by approximately 87%, though may result in irregular bleeding patterns 1
- Combined hormonal contraceptives: Effective for reducing menstrual blood loss when hormonal options are appropriate 2
- Antifibrinolytic agents (e.g., tranexamic acid): Reduce bleeding symptoms in patients with fibroids or other causes of heavy bleeding 4
Treatment Algorithm
Initial assessment:
- Evaluate severity of bleeding (bleeding that saturates a large pad or tampon hourly for ≥4 hours requires urgent evaluation) 1
- Rule out pregnancy in reproductive-age women 1, 2
- Check for signs of hemodynamic instability (tachycardia, hypotension) 1
- Evaluate for underlying gynecological problems (STDs, uterine conditions like polyps or fibroids) 4, 2
First-line treatment:
If bleeding persists after first-line treatment:
For refractory cases:
Comparative Effectiveness
- Tranexamic acid reduces menstrual blood loss by 54% compared to 20% reduction with mefenamic acid (an NSAID) 6
- LNG-IUD is more effective than tranexamic acid for reducing menstrual blood loss 5
- Tranexamic acid is significantly more effective than placebo, NSAIDs, and oral cyclical luteal phase progestins 5, 7
Special Considerations
- Enhanced counseling about expected bleeding patterns improves treatment adherence 4
- If bleeding remains unacceptable despite treatment, counsel on alternative methods or refer for surgical management 4
- Up to 20% of women with heavy menstrual bleeding may have an underlying inherited bleeding disorder 2
- Tranexamic acid significantly improves quality of life in women treated for heavy menstrual bleeding 5, 8
Common Pitfalls and Caveats
- Avoid tranexamic acid in women with active thromboembolic disease or history of thrombosis 2, 5
- NSAIDs should be used at the lowest effective dose for the shortest duration to minimize gastrointestinal side effects 3, 9
- For Cu-IUD users, unscheduled spotting or light bleeding, as well as heavy bleeding, is common during the first 3-6 months and generally decreases with continued use 4
- Hormone-free intervals are not recommended more than once per month for CHC users on extended or continuous regimens as contraceptive effectiveness might be reduced 4